The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment for the condition, which affects more than one billion people globally, according to the agency
Naltrexone blocks those opioid receptors
Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells via the miR-148a/PXR axis
Natural alternatives to Ozempic can support blood sugar control and weight management, especially through diet, exercise, sleep, and stress reduction, but they rarely match prescription effectiveness
If constipation is already a problem on your medication, drinking without aggressive hydration will make it worse
Aunque los agonistas GLP-1 son generalmente seguros y efectivos, existen situaciones especficas en las que debe comunicarse con su proveedor de atencin mdica para evaluar la respuesta al tratamiento o abordar posibles complicaciones